Secondary Hyperparathyroidism

Etelcalcetide May Slow Left Ventricular Hypertrophy in SHPT

Publish Date April 14, 2021

Increases in FGF23 may lead to cardiac remodeling in these patients, investigators suggest.

Study Finds Evidence of SHPT-Related Myocardial Damage

Publish Date March 18, 2021

Cardiovascular MRI provided evidence of a relationship between prolonged exposure to elevated PTH and myocardial damage.

Bisphosphonates May Treat Calciphylaxis in Kidney Transplant Recipients

Publish Date March 17, 2021

Moderate to severe hyperparathyroidism after kidney transplantation may have predisposed 2 cases to calciphylaxis, according to investigators.

Parathyroidectomy May Ease Non-Dipping Heart Rate in CKD

Publish Date March 12, 2021

Disturbed circadian rhythms, specifically a potentially life-threatening non-dipping heart rate, may represent a novel prognostic marker for CKD patients, according to investigators.

Calcimimetic Found More Effective in Suppressing Calcification in HD

Publish Date March 11, 2021

Trial findings suggest a calcimimetic may be more effective than a VDRA at reducing calcification in patients receiving hemodialysis.

Nicotinamide May Improve Phosphate Control in Hemodialysis Patients

Publish Date March 10, 2021

Nicotinamide modulates expression of the sodium-dependent phosphate cotransporter 2b and thereby may inhibit intestinal phosphate absorption, according to investigators.

Conservative CKD-MBD Management at Dialysis Initiation on the Rise

Publish Date February 22, 2021

Trends suggest that clinical practice could be driven heavily by providers’ preferences and beliefs, resulting in substantial practice variation.

SHPT in Nondialysis CKD Associated With Major Adverse Events

Publish Date February 19, 2021

Risk prevention efforts and increased surveillance and monitoring of patients with nondialysis-dependent CKD are needed, according to investigators.

High Predialysis Parathyroid Hormone Linked With Uncontrolled SHPT

Publish Date February 18, 2021

Earlier PTH suppression might decrease the risk of uncontrolled secondary hyperparathyroidism among patients with chronic kidney disease, according to investigators.

Investigators ID Risk Factor for Post-Parathyroidectomy Hypocalcemia

Publish Date February 17, 2021

In a study, hypocalcemia persisted for more than 12 months after parathyroidectomy in 64% of patients with secondary hyperparathyroidism.